Phage WA are committed to tackling antimicrobial resistance (AMR) through phage therapy.
Our team actively collect phages that target specific bacteria, ensure these are safe for use and aim to treat humans with these phages through phage therapy. We are also involved in clinical trials to ensure continued and optimal use of phage therapy.
Phage WA operate within the Wal-yan Respiratory Research Centre, a powerhouse partnership between Telethon Kids Institute, Perth Children’s Hospital Foundation and Perth Children’s Hospital.
Working with community
New study to find COVID-fighting properties in existing medications thanks to national grant
Telethon Kids Institute researchers awarded $11 million to support vital child health research
Patients with antibiotic-resistant lung infections to receive promising phage therapy treatment as part of new trial led by Telethon Kids Institute Researcher Anthony Kicic
New treatment option for West Australians with cystic fibrosis one step closer thanks to generosity of Conquer Cystic Fibrosis
Funding boost for cancer, antimicrobial resistance, and pain management treatments
Could Perth lakes hold the secret to fighting antibiotic-resistant superbugs?
Discover. Prevent. Cure.